Log In
Print
BCIQ
Print
Print this Print this
 

Cycloset, bromocriptine mesylate

Also known as: formerly Ergoset

  Manage Alerts
Collapse Summary General Information
Company VeroScience LLC
DescriptionBromocriptine timed-release tablets
Molecular Target Dopamine D2 receptor
Mechanism of ActionDopamine D2 receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat diabetes; Treat diabetes and obesity; Treat insulin secretory dysfunction; Treat non-insulin-dependent Type II diabetes; Treat obese Type II diabetics; Treat obesity or diabetes; Treat Type II diabetes; Treat Type II diabetes requiring insulin
Regulatory Designation

Partner

Salix Pharmaceuticals Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today